Roche is now marketing Vesanoid
Roche is now marketing Vesanoid...in both the U.S. and Canada. It's the first vitamin A derivative to be approved for cancer.
Vesanoid is an oral form of tretinoin...the same ingredient that's in Retin-A.
Retinoids don't kill cancer cells like traditional chemo-therapy. Instead they help induce remission by getting immature cancer cells to differentiate and mature normally. These mature cells then die naturally.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote